Novo Integrated Sciences Inc (NVOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 11-2020 | 08-2020 | 05-2020 | 02-2020 | 11-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -773 | -4,924 | -696 | -595 | -89 |
| Depreciation Amortization | 358 | 1,445 | 55 | 41 | 20 |
| Accounts receivable | 275 | -229 | 306 | -19 | -166 |
| Accounts payable and accrued liabilities | 9 | -276 | -448 | -340 | -71 |
| Other Working Capital | -130 | -871 | -590 | -632 | -354 |
| Other Operating Activity | 114 | 4,413 | 948 | 965 | 362 |
| Operating Cash Flow | $-148 | $-442 | $-426 | $-579 | $-298 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -12 | -4 | -1 | N/A |
| Net Acquisitions | N/A | 0 | -264 | -264 | 114 |
| Other Investing Activity | 0 | 669 | 0 | 0 | 0 |
| Investing Cash Flow | $0 | $657 | $-268 | $-265 | $114 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 81 | 81 | N/A | N/A |
| Debt Repayment | N/A | -268 | N/A | N/A | N/A |
| Common Stock Issued | 92 | 113 | 113 | 113 | 113 |
| Other Financing Activity | -48 | -199 | -151 | -140 | -83 |
| Financing Cash Flow | $44 | $-272 | $44 | $-27 | $30 |
| Exchange Rate Effect | 7 | 40 | -39 | -3 | 2 |
| Beginning Cash Position | 2,068 | 2,084 | 2,084 | 2,084 | 2,084 |
| End Cash Position | 1,970 | 2,068 | 1,394 | 1,209 | 1,932 |
| Net Cash Flow | $-97 | $-16 | $-689 | $-874 | $-152 |
| Free Cash Flow | |||||
| Operating Cash Flow | -148 | -442 | -426 | -579 | -298 |
| Capital Expenditure | N/A | -12 | -4 | -1 | N/A |
| Free Cash Flow | -148 | -454 | -430 | -580 | -298 |